Bluejay Diagnostics, Inc. (BJDX) Earnings History
Annual and quarterly earnings data from 2019 to 2024
Loading earnings history...
BJDX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
BJDX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | 19.6% | -3741.5% | -3733.1% |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export BJDX earnings history in CSV or JSON format
Free sign-in required to download data
Bluejay Diagnostics, Inc. (BJDX) Earnings Overview
As of May 8, 2026, Bluejay Diagnostics, Inc. (BJDX) reported trailing twelve-month net income of -$7M, reflecting +42.1% year-over-year growth. The company earned $-4.35 per diluted share over the past four quarters.
Looking at the long-term picture, BJDX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$757,716 in fiscal 2019.
Bluejay Diagnostics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including QDEL (-$1.21B net income, -41.5% margin), CUE (-$27M net income, -96.9% margin), LFMD (-$17M net income, -3.7% margin), BJDX has comparable earnings metrics. Compare BJDX vs QDEL →
BJDX Earnings vs Peers
Earnings metrics vs comparable public companies
BJDX Historical Earnings Data (2019–2024)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$8M | +22.5% | -$7M | $-42.08 | - | - |
| 2023 | -$10M | -7.1% | -$10M | $-72.62 | - | - |
| 2022 | -$9M | -149.3% | -$9M | $-73.22 | -3733.1% | -3741.5% |
| 2021 | -$4M | -231.3% | -$3M | $-29.67 | - | - |
| 2020 | -$1M | -48.6% | -$1M | $-14.19 | - | - |
| 2019 | $-757,716 | - | -$2M | $-9.55 | - | - |
See BJDX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BJDX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BJDX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBJDX — Frequently Asked Questions
Quick answers to the most common questions about buying BJDX stock.
Is BJDX growing earnings?
BJDX EPS is $-4.35, with earnings growth accelerating to +42.1%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-7M.
What are BJDX's profit margins?
Bluejay Diagnostics, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are BJDX's earnings?
BJDX earnings data spans 2019-2024. The accelerating earnings trend is +42.1% YoY. Historical data enables comparison across business cycles.